Evidence map›Paper›PMID 37280629›Full record

ReviewBMC endocrine disorders2023

Mediastinal parathyroid carcinoma: a case report and review of the literature.

Yan Bao, Ganjun Kang, Xiaoyan Wu, Jing Li, Yan Huang, Ye Wang

Open access · goldAbstract readReviewCase Reports
In one paragraph

Review in BMC endocrine disorders, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Critical Insights into Parathyroid Cancer.Journal of cancer science and clinical therapeutics · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yan BaoDepartment of Endocrinology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. baoyan713@126.com.ORCID http://orcid.org/0000-0001-7596-9885
Ganjun KangDepartments of Thoracic Surgery, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Xiaoyan WuDepartment of Pathology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Jing LiDepartment of Endocrinology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Yan HuangDepartment of Endocrinology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Ye WangDepartment of Endocrinology, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
Wuhan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParathyroid carcinoma (PC) is an uncommon cause of primary hyperparathyroidism (PHPT) and particularly rare in the mediastinum. Herein, we present a case of mediastinal PC and conduct a related literature review. CASE PRESENTATION: We described a case of a 50-year-old female patient with PHPT due to mediastinal PC. She was initially admitted to a local hospital in her hometown with hypercalcemia and high blood concentrations of PTH (parathyroid hormone). The patient underwent neck parathyroidectomy and pathological examination suggested parathyroid adenoma. Although the overproduction of serum calcium and PTH declined after the surgery, calcium and PTH increased again one month later, so the patient was transferred to our hospital. A 99

conclusionWith this study, we emphasize the importance of accurate preoperative diagnosis of mediastinal PC and improve clinicians' understanding of the disease.

Indexed as

Hyperparathyroidism, PrimaryParathyroid NeoplasmsCalciumFemaleHumansMediastinumMiddle AgedParathyroidectomyParathyroid HormoneCalciumParathyroid HormoneCase reportEctopicMediastinumParathyroid carcinomaPrimary hyperparathyroidism

Identifiers

PMID37280629
PMCPMC10243010
OpenAlexW4379534886

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.